OSRH
Price
$0.63
Change
-$0.07 (-10.00%)
Updated
Dec 3 closing price
Capitalization
16.19M
Intraday BUY SELL Signals
YDES
Price
$13.17
Change
+$0.21 (+1.62%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
880.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

OSRH vs YDES

Header iconOSRH vs YDES Comparison
Open Charts OSRH vs YDESBanner chart's image
OSR Holdings
Price$0.63
Change-$0.07 (-10.00%)
Volume$595.89K
Capitalization16.19M
YD Bio
Price$13.17
Change+$0.21 (+1.62%)
Volume$1.65K
Capitalization880.81M
OSRH vs YDES Comparison Chart in %
OSRH
Daily Signal:
Gain/Loss:
YDES
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OSRH vs. YDES commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSRH is a Hold and YDES is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (OSRH: $0.70 vs. YDES: $13.13)
Brand notoriety: OSRH and YDES are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OSRH: 5% vs. YDES: 96%
Market capitalization -- OSRH: $16.19M vs. YDES: $913.96M
OSRH [@Biotechnology] is valued at $16.19M. YDES’s [@Biotechnology] market capitalization is $913.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSRH’s FA Score shows that 1 FA rating(s) are green whileYDES’s FA Score has 0 green FA rating(s).

  • OSRH’s FA Score: 1 green, 4 red.
  • YDES’s FA Score: 0 green, 5 red.
According to our system of comparison, OSRH is a better buy in the long-term than YDES.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OSRH’s TA Score shows that 5 TA indicator(s) are bullish while YDES’s TA Score has 6 bullish TA indicator(s).

  • OSRH’s TA Score: 5 bullish, 5 bearish.
  • YDES’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, YDES is a better buy in the short-term than OSRH.

Price Growth

OSRH (@Biotechnology) experienced а -14.18% price change this week, while YDES (@Biotechnology) price change was +41.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
YDES($881M) has a higher market cap than OSRH($16.2M). YDES YTD gains are higher at: 16.711 vs. OSRH (-93.923).
OSRHYDESOSRH / YDES
Capitalization16.2M881M2%
EBITDA-12.05MN/A-
Gain YTD-93.92316.711-562%
P/E RatioN/AN/A-
Revenue105KN/A-
Total Cash1.58MN/A-
Total Debt4.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
OSRHYDES
RSI
ODDS (%)
Bearish Trend 7 days ago
16%
Bullish Trend 7 days ago
22%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
57%
Bullish Trend 7 days ago
19%
Momentum
ODDS (%)
Bullish Trend 7 days ago
59%
Bullish Trend 7 days ago
22%
MACD
ODDS (%)
Bullish Trend 7 days ago
40%
Bullish Trend 7 days ago
19%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
47%
Bullish Trend 7 days ago
22%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
69%
Bearish Trend 7 days ago
17%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 7 days ago
22%
Declines
ODDS (%)
Bearish Trend 15 days ago
81%
Bearish Trend 15 days ago
12%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
17%
Bullish Trend 7 days ago
50%
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
11%
View a ticker or compare two or three
Interact to see
Advertisement
OSRH
Daily Signal:
Gain/Loss:
YDES
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNXP15.510.29
+1.91%
Tonix Pharmaceuticals Holding Corp
HBNC17.260.10
+0.58%
Horizon Bancorp
KNF74.010.20
+0.28%
Knife River Corp
CCEP92.420.09
+0.10%
Coca-Cola Europacific Partners plc
RBOT2.61-0.05
-1.84%
Vicarious Surgical

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
-1.53%
MIST - OSRH
29%
Poorly correlated
-1.49%
EDSA - OSRH
23%
Poorly correlated
+1.17%
EDIT - OSRH
22%
Poorly correlated
-3.65%
LEXX - OSRH
21%
Poorly correlated
-0.94%
VERA - OSRH
21%
Poorly correlated
+12.88%
More

YDES and

Correlation & Price change

A.I.dvisor tells us that YDES and OTLK have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YDES and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YDES
1D Price
Change %
YDES100%
+5.04%
OTLK - YDES
21%
Poorly correlated
-1.08%
LIMN - YDES
4%
Poorly correlated
-6.56%
JBIO - YDES
4%
Poorly correlated
-3.80%
OSRH - YDES
3%
Poorly correlated
-1.53%
HIND - YDES
3%
Poorly correlated
+0.20%
More